Evolutionary Genomics

Evolutionary Genomics Receivables

Accounts Receivable of Evolutionary Genomics (FNAM) as of Oct 10, 2026.

Receivables

0.00USD

Last updated:

Accounts Receivable of Evolutionary Genomics is 2020 0.00 USD. Accounts Receivable of Evolutionary Genomics was 2019 6,900.00 USD. It decreases by % lower compared to the previous year.

The Evolutionary Genomics Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2014
40,600.00 USD
Jan 1, 2015
16,200.00 USD
Jan 1, 2016
9,300.00 USD
Jan 1, 2017
0.00 USD
Jan 1, 2018
40,400.00 USD
Jan 1, 2019
6,900.00 USD
Jan 1, 2020
0.00 USD
The Evolutionary Genomics Receivables history
YEARReceivablesYoY
0.00USD-100.00%
6,900.00USD-82.92%
40,400.00USD—
0.00USD-100.00%
9,300.00USD-42.59%
16,200.00USD-60.10%
40,600.00USD—
Access this data via the Eulerpool API
Get Free API Key

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

On Eulerpool you can find the complete historical development of Accounts Receivable Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Evolutionary Genomics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Evolutionary Genomics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Evolutionary Genomics